In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enabling E-Biotech

Executive Summary

Approached creatively, the Web offers biotechs a distribution medium for the selling of expertise as expertise, rather than as therapeutic products, and its application to many problems, not a specific few. Such a strategy is directly contradictory to a biotech model built around exclusive collaborations. But the Web-enabled possibility of selling expertise broadly changes the biotech's customer base. Where biotechs currently look to sell a few, high-cost deals in which most of the funding comes at the end of a highly risky project, the Web-biotech sells to many subscribers who pay up front.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

IV001077

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel